VistaGen Therapeutics, Inc. (VTGN)
USD 2.32
(-4.53%)
USD 2.32
(-4.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.81 Million | -49.71 Million | -45.25 Million | -12.07 Million | -15.75 Million | -14.52 Million |
| Net Income | -29.36 Million | -59.24 Million | -47.76 Million | -17.93 Million | -20.77 Million | -24.58 Million |
| Depreciation & Amortization | 568 Thousand | 509.8 Thousand | 711.1 Thousand | 117.6 Thousand | 103.1 Thousand | 91.2 Thousand |
| Deferred income taxes | - | 932.8 Million | - | -2.53 Million | 826.9 Thousand | 145.5 Thousand |
| Stock-based compensation | 2.18 Million | 3.33 Million | 3.48 Million | 2.3 Million | 3.82 Million | 3.44 Million |
| Change in working capital | 793 Thousand | 2.02 Million | -1.91 Million | 3.43 Million | 160.3 Thousand | 1.71 Million |
| Other non-cash items | 2.8 Million | -929.14 Million | 232 Thousand | 2.53 Million | 105.9 Thousand | 4.66 Million |
| Investing Cash Flow | -61 Thousand | -740.3 Thousand | -200.4 Thousand | -275.4 Thousand | - | -174 Thousand |
| Investments in PPE | -61 Thousand | -212 Thousand | -200.4 Thousand | -275.4 Thousand | - | -174 Thousand |
| Acquisitions | - | -528.3 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -740.3 Million | -200.4 Million | -275.4 Million | - | -174 Million |
| Financing Cash Flow | 128.4 Million | -1.04 Million | 10.48 Million | 114.1 Million | 4.01 Million | 17.42 Million |
| Debt repayment | -985 Thousand | -1500.00 | -3000.00 | -3300.00 | -3000.00 | -2700.00 |
| Dividends payments | - | - | -945.1 Million | -1.38 Billion | -1.26 Billion | -1.13 Billion |
| Common Stock Repurchased | - | -173.9 Thousand | - | - | - | - |
| Common Stock Issuance | 129.38 Million | -6400.00 | 10.48 Million | 114.48 Million | 4.3 Million | 17.64 Million |
| Other Financing Activities | 34.94 Million | -1.04 Million | 10.48 Million | 114.1 Million | 4.01 Million | 17.42 Million |
| Accounts receivables | - | - | - | -40.6 Thousand | 300 Thousand | -300 Thousand |
| Accounts payables | 522 Thousand | -932.8 Thousand | 1.68 Billion | 51 Million | -390.7 Million | 22.7 Million |
| Inventory | - | - | - | -51 Million | 390.7 Million | -20.77 Million |
| Other working capital | 271 Thousand | 2.96 Million | -1.68 Billion | 3.47 Million | -139.7 Thousand | 90.5 Thousand |
| Cash at beginning of period | 16.63 Million | 68.13 Million | 103.1 Million | 1.35 Million | 13.1 Million | 10.37 Million |
| Cash at end of period | 119.16 Million | 16.63 Million | 68.13 Million | 103.1 Million | 1.35 Million | 13.1 Million |
| Capital Expenditure | -61 Thousand | -212 Thousand | -200.4 Thousand | -275.4 Thousand | - | -174 Thousand |
| Effect of forex changes on cash | - | -1.00 | - | - | - | - |
| Net cash flow / Change in cash | 102.52 Million | -51.49 Million | -34.97 Million | 101.75 Million | -11.74 Million | 2.72 Million |
| Free Cash Flow | -25.87 Million | -49.92 Million | -45.45 Million | -12.34 Million | -15.75 Million | -14.7 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -29.36 Million | -9.52 Million | -6.34 Million | -6.58 Million | -6.9 Million | -59.24 Million |
| Depreciation & Amortization | 568 Thousand | 146.5 Thousand | 143.2 Thousand | 140.3 Thousand | 340 Thousand | 509.8 Thousand |
| Deferred income taxes | - | -1.21 Billion | -524.4 Thousand | 1.05 Million | 1.21 Billion | 932.8 Million |
| Stock-based compensation | 2.18 Million | 522.5 Thousand | 506.7 Thousand | 583.7 Thousand | 569.1 Thousand | 3.33 Million |
| Change in working capital | 793 Thousand | 1.64 Million | 1.16 Million | -325.9 Thousand | -1.69 Million | 2.02 Million |
| Other non-cash items | 2.8 Million | -1.09 Million | 524.4 Thousand | -1.05 Million | -1.21 Billion | -929.14 Million |
| Investing Cash Flow | -61 Thousand | -28.7 Thousand | -32.3 Thousand | - | - | -740.3 Thousand |
| Investments in PPE | -61 Thousand | -28.7 Thousand | -32.3 Thousand | - | - | -212 Thousand |
| Acquisitions | - | - | - | - | - | -528.3 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -740.3 Million |
| Financing Cash Flow | 128.4 Million | -167.8 Thousand | 93.51 Million | 34.17 Million | 875.6 Thousand | -1.04 Million |
| Debt repayment | -985 Thousand | -1000.00 | -500.00 | -784.6 Thousand | -200.9 Thousand | -1500.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -168.8 Thousand | - | - | - | -173.9 Thousand |
| Common Stock Issuance | 129.38 Million | -168.8 Thousand | 93.51 Million | 34.96 Million | 1.07 Million | -6400.00 |
| Other Financing Activities | 34.94 Million | 1000.00 | 93.51 Million | 34.17 Million | 875.6 Thousand | -1.04 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 522 Thousand | 1.91 Million | 268.7 Thousand | -450.3 Thousand | -1.21 Million | -932.8 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 271 Thousand | -266.9 Thousand | 895.8 Thousand | 124.4 Thousand | -482.3 Thousand | 2.96 Million |
| Cash at beginning of period | 16.63 Million | 126.55 Million | 37.6 Million | 9.62 Million | 16.63 Million | 68.13 Million |
| Cash at end of period | 119.16 Million | 119.16 Million | 126.55 Million | 37.6 Million | 9.62 Million | 16.63 Million |
| Capital Expenditure | -61 Thousand | -28.7 Thousand | -32.3 Thousand | - | - | -212 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -1.00 |
| Net cash flow / Change in cash | 102.52 Million | -7.39 Million | 88.95 Million | 27.98 Million | -7.01 Million | -51.49 Million |
| Free Cash Flow | -25.87 Million | -7.22 Million | -4.56 Million | -6.18 Million | -7.89 Million | -49.92 Million |
ONTO
LSPD
AAMC
TTWO
RUSTOMJEE
SAPGF